Novartis AG
(NYSE : NVS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.12%42.140.9%$981.01m
MRKMerck & Co., Inc.
2.00%81.090.6%$801.95m
JNJJohnson & Johnson
0.43%138.710.7%$766.10m
BMYBristol-Myers Squibb Company
0.64%47.741.4%$672.48m
LLYEli Lilly and Company
1.36%118.161.0%$520.33m
ABBVAbbVie, Inc.
0.77%81.502.2%$452.75m
NVSNovartis AG Sponsored ADR
1.91%83.960.2%$212.34m
AZNAstraZeneca PLC Sponsored ADR
1.65%38.511.3%$191.81m
GSKGlaxoSmithKline plc Sponsored ADR
1.80%40.100.2%$100.36m
NVONovo Nordisk A/S Sponsored ADR Class B
1.84%48.410.1%$63.89m
SNYSanofi Sponsored ADR
2.22%42.090.2%$46.91m
LCILannett Company, Inc.
-1.14%6.0636.7%$10.04m
AKTXAkari Therapeutics Plc Sponsored ADR
-3.55%2.441.6%$3.45m
EPIXESSA Pharma Inc
-3.49%2.080.1%$0.01m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.